CRP and hyperuricemia: A cohort study involving 100 participants with asymptomatic hyperuricemia revealed that, compared with HCs, those receiving allopurinol experienced significant reductions in office systolic and diastolic blood pressure, central systolic blood pressure, pulse pressure, carotid intima-media thickness, and hs-CRP.